Edit the instructions. Amoxicillin + clavulanic acid in dosage forms - dispersible tablets, film-coated tablets, film-coated tablets

December 16, 2016
Active substances:
Trade names:
ICD-10:
I.A50-A64.A54    Gonococcal infection
VIII.H65-H75.H66    Purulent and unspecified otitis media
X.J00-J06.J01    Acute Sinusitis
X.J00-J06.J02    Acute pharyngitis
X.J00-J06.J03    Acute tonsillitis
X.J00-J06.J04    Acute laryngitis and tracheitis
X.J10-J18.J15    Bacterial pneumonia, not elsewhere classified
X.J20-J22.J20    Acute bronchitis
X.J30-J39.J31    Chronic rhinitis, nasopharyngitis and pharyngitis
X.J30-J39.J32    Chronic Sinusitis
X.J30-J39.J35.0    Chronic tonsillitis
X.J30-J39.J37    Chronic laryngitis and laryngotracheitis
X.J40-J47.J42    Chronic bronchitis, unspecified
XI.K00-K14.K04    Diseases of pulp and periapical tissues
XI.K65-K67.K65.0    Acute peritonitis
XII.L00-L08.L01    Impetigo
XII.L00-L08.L02    Abscess of skin, boil and carbuncle
XII.L00-L08.L03    Phlegmon
XII.L00-L08.L08.0    Pyoderma
XIII.M00-M03.M00    Pyogenic arthritis
XIII.M86-M90.M86    Osteomyelitis
XIV.N10-N16.N10    Acute tubulointerstitial nephritis
XIV.N10-N16.N11    Chronic tubulointerstitial nephritis
XIV.N30-N39.N30    Cystitis
XIV.N30-N39.N34    Urethritis and urethral syndrome
XIV.N40-N51.N41    Inflammatory diseases of the prostate
XIV.N70-N77.N70    Salpingitis and oophoritis
XIV.N70-N77.N71.0    Acute inflammatory disease of the uterus
XIV.N70-N77.N72    Inflammatory disease of the cervix
XIV.N70-N77.N73.0    Acute parametritis and pelvic cellulite
XV.O85-O92.O85    Postpartum sepsis
XIX.T79.T79.3    Post-traumatic wound infection, not elsewhere classified
XV.O00-O08.O08.0    Infection of the genital tract and pelvic organs caused by abortion, ectopic and molar pregnancy
Amoxicillin, clavulanic acid, augmentin, sinusitis, tonsillitis, otitis media, cystitis, urethritis, pneumonia

The need to bring the text of these instructions in accordance with the instructions in force in the Russian Federation for the drug Augmentin, presented on the portal of GRL in a dosage form, tablets coated with a film coating of 500 + 125 mg, including the section "Method of administration and dose" of the drug in adults and children over the age of 12 years or with a body weight of more than 40 kg, it is necessary to indicate: "Adults and children 12 years of age or older or with a body weight of 40 kg or more: 1 tablet 500 mg + 125 mg 3 times a day" .